In a similar trial, GPM supplementation was able to stop all changes brought on by experimental infection with P. aeruginosa (down-regulation of Nucleoside Triphosphate diphosphohydrolase-NTPDase, with an increase in adenosine deaminase-ADA, metabolites of NOx, MPO and CAT activities). The gene discussed is ADA; the disease is infection.